Tracy L. Bahl

Managing Director, Valtruis, a WCAS Company

📍 Miami, Florida, United States🔄 Updated September 2026💼 4 investments📅 14 years investing🗓 Last invested Apr 2021
VC🌍 United States
4
Total investments
0
Early stage
0
Mid stage
1
Late stage
14y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Apr 2021
Andros is a health technology company that solves the multiple challenges healthcare organizations experience building, managing, and optimizing provider networks. Built on the industry’s largest provider data resource, the Andros software suite leverages data intelligence and automated workflows to recruit, contract, credential, and monitor healthcare providers and networks nationwide. Innovative health plans, governmental entities, and telehealth companies deliver healthcare to counties containing over 90% of the United States’ population through networks built and managed with Andros technology.
Board Member
May 2020
Glooko enhances health outcomes of people with diabetes through personalized, intelligent, connected care platforms. Our proven technologies make lives better by revolutionizing the connection between patients and providers, as well as driving patient engagement and adherence via digital insights. Glooko solutions are globally deployed in more than 30 countries, 10,000+ clinical locations and integrated with over 200 devices.
Experience · 9 entries
All (9)
Investments (4)
Founder (1)
Board (4)
2021
Board Member
Apr 2021
Andros is a health technology company that solves the multiple challenges healthcare organizations experience building, managing, and optimizing provider networks. Built on the industry’s largest provider data resource, the Andros software suite leverages data intelligence and automated workflows to recruit, contract, credential, and monitor healthcare providers and networks nationwide. Innovative health plans, governmental entities, and telehealth companies deliver healthcare to counties containing over 90% of the United States’ population through networks built and managed with Andros technology.
Managing Director
Feb 2021
Valtruis invests in, builds, and partners with companies that challenge the healthcare industry’s status quo and revolutionize the way care is accessed, delivered, experienced, and paid for. Founded on a commitment to accelerate meaningful change, Valtruis brings the functional expertise, access to capital and an expansive network that advance our partners’ evolution from early-stage development to industry-leading enterprises. Together, Valtruis and its partner companies will break through the systemic barriers in the healthcare industry to reduce costs, expand access, increase quality and radically improve the patient experience.
Operating Partner
Jan 2021
WCAS is a leading U.S. private equity firm focused on two target industries: technology and healthcare. Since its founding in 1979, the firms strategy has been to partner with outstanding management teams and build value for its investors through a combination of operational improvements, growth initiatives and strategic acquisitions. WCAS has deep experience in acquiring founder-led businesses and corporate carve-outs. The firm has raised and managed funds totaling over $31 billion of committed capital.
2020
Executive Partner
Jul 2020
Ardan Equity is the Healthcare Software Private Equity Firm®— the first alternative investment manager dedicated exclusively to the healthcare and life sciences software and data sector. Ardan partners collaboratively with founders and management teams to accelerate growth and create differentiated, market leading platforms. As founders, operators and investors, Ardan has built many of the defining healthcare software pillars across life sciences, payer, provider and employer markets. Ardan uniquely leverages its proprietary growth strategies, trusted network and proven executives to drive superior risk-adjusted performance. For more information, please visit the Ardan Equity website www.ardanequity.com
Board Member
May 2020
Glooko enhances health outcomes of people with diabetes through personalized, intelligent, connected care platforms. Our proven technologies make lives better by revolutionizing the connection between patients and providers, as well as driving patient engagement and adherence via digital insights. Glooko solutions are globally deployed in more than 30 countries, 10,000+ clinical locations and integrated with over 200 devices.
Show all 9 entries ↓
Investment activity
2012–2021 · 4 investments
20121201312020120211
Recent (last 2 years)Earlier